FDA Class II · Drug · July 8, 2026
Cinacalcet Hydrochloride Tablets recall — Cipla USA, Inc.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Official ID D-0676-2026 · Official record ↗
Cipla USA recalls
3 recent recalls on record for Cipla USA in CPSC, NHTSA, and FDA data as of July 24, 2026 at 1:09 AM UTC.
Models with recalls
All Cipla USA recalls
FDA Class II · Drug · July 8, 2026
Cinacalcet Hydrochloride Tablets recall — Cipla USA, Inc.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Official ID D-0675-2026 · Official record ↗
FDA Class II · Drug · July 8, 2026
Cinacalcet Hydrochloride Tablets recall — Cipla USA, Inc.
cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).
Official ID D-0661-2026 · Official record ↗
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & egg products ↗ (not yet aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked July 24, 2026 at 1:09 AM UTC.